125 related articles for article (PubMed ID: 30994834)
1. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients.
Uint L; Bastos GM; Thurow HS; Borges JB; Hirata TDC; França JID; Hirata MH; Sousa AGMR
Rev Assoc Med Bras (1992); 2019 Mar; 65(3):361-369. PubMed ID: 30994834
[TBL] [Abstract][Full Text] [Related]
2. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
[TBL] [Abstract][Full Text] [Related]
3. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
[TBL] [Abstract][Full Text] [Related]
4. Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly patients with refractory depression.
Zhao X; Li Y; Tian Q; Zhu B; Zhao Z
J Int Med Res; 2019 May; 47(5):1848-1855. PubMed ID: 30616482
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men.
Su SC; Sun MT; Wen MJ; Lin CJ; Chen YC; Hung YJ
Int J Psychiatry Med; 2011; 42(3):211-26. PubMed ID: 22439294
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.
Yang JJ; Wang N; Yang C; Shi JY; Yu HY; Hashimoto K
Biol Psychiatry; 2015 Feb; 77(3):e19-e20. PubMed ID: 25104172
[No Abstract] [Full Text] [Related]
7. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.
Rethorst CD; Greer TL; Toups MS; Bernstein I; Carmody TJ; Trivedi MH
Transl Psychiatry; 2015 Aug; 5(8):e611. PubMed ID: 26241349
[TBL] [Abstract][Full Text] [Related]
8. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
9. Correlation between interleukin-6 levels and methadone maintenance therapy outcomes.
Lu RB; Wang TY; Lee SY; Chen SL; Chang YH; See Chen P; Lin SH; Chu CH; Huang SY; Tzeng NS; Lee IH; Chin Chen K; Kuang Yang Y; Chen P; Chen SH; Hong JS
Drug Alcohol Depend; 2019 Nov; 204():107516. PubMed ID: 31513981
[TBL] [Abstract][Full Text] [Related]
10. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.
Haile CN; Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Foulkes A; Iqbal S; Mahoney JJ; De La Garza R; Charney DS; Newton TF; Mathew SJ
Int J Neuropsychopharmacol; 2014 Feb; 17(2):331-6. PubMed ID: 24103211
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents.
Hatch JK; Scola G; Olowoyeye O; Collins JE; Andreazza AC; Moody A; Levitt AJ; Strauss BH; Lanctot KL; Goldstein BI
J Clin Psychiatry; 2017 Mar; 78(3):e286-e293. PubMed ID: 28199074
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review.
Yang C; Wardenaar KJ; Bosker FJ; Li J; Schoevers RA
J Affect Disord; 2019 Oct; 257():640-649. PubMed ID: 31357161
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
[TBL] [Abstract][Full Text] [Related]
15. The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders.
Wang TY; Lee SY; Chen SL; Chung YL; Li CL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Hsieh TH; Chiu YC; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 26865313
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
Li Z; Zhang C; Fan J; Yuan C; Huang J; Chen J; Yi Z; Wang Z; Hong W; Wang Y; Lu W; Guan Y; Wu Z; Su Y; Cao L; Hu Y; Hao Y; Liu M; Yu S; Cui D; Xu L; Song Y; Fang Y
Br J Psychiatry; 2014 Jul; 205(1):29-35. PubMed ID: 24764546
[TBL] [Abstract][Full Text] [Related]
17. Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow-up study from adolescence into adulthood.
Mesman E; Hillegers MH; Ambree O; Arolt V; Nolen WA; Drexhage HA
Bipolar Disord; 2015 Feb; 17(1):39-49. PubMed ID: 25039314
[TBL] [Abstract][Full Text] [Related]
18. Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features.
Patas K; Penninx BW; Bus BA; Vogelzangs N; Molendijk ML; Elzinga BM; Bosker FJ; Oude Voshaar RC
Brain Behav Immun; 2014 Feb; 36():71-9. PubMed ID: 24140302
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
[TBL] [Abstract][Full Text] [Related]
20. Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration.
Xiong P; Zeng Y; Wu Q; Han Huang DX; Zainal H; Xu X; Wan J; Xu F; Lu J
J Clin Psychiatry; 2014 Aug; 75(8):e794-801. PubMed ID: 25191916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
